TNK2

tyrosine kinase non receptor 2, the group of MicroRNA protein coding host genes|TNK family tyrosine kinases

Basic information

Region (hg38): 3:195863364-195911945

Links

ENSG00000061938NCBI:10188OMIM:606994HGNC:19297Uniprot:Q07912AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • infantile-onset mesial temporal lobe epilepsy with severe cognitive regression (Supportive), mode of inheritance: AR

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TNK2 gene.

  • not_provided (244 variants)
  • not_specified (230 variants)
  • TNK2-related_disorder (20 variants)
  • Parkinson_disease (4 variants)
  • Abnormality_of_neuronal_migration (2 variants)
  • Epileptic_encephalopathy (1 variants)
  • Autosomal_recessive_infantile_epilepsy (1 variants)
  • TNK2-associated_Epilepsy_syndrome (1 variants)
  • Infantile_epilepsy (1 variants)
  • Developmental_and_epileptic_encephalopathy (1 variants)
  • See_cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNK2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001382273.1. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
69
clinvar
25
clinvar
94
missense
1
clinvar
263
clinvar
18
clinvar
7
clinvar
289
nonsense
2
clinvar
2
start loss
0
frameshift
3
clinvar
3
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total 1 0 269 87 32

Highest pathogenic variant AF is 0.00000371889

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TNK2protein_codingprotein_codingENST00000381916 1548582
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
8.22e-120.9931256780701257480.000278
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.2027106951.020.00004796863
Missense in Polyphen225259.450.867222555
Synonymous-4.894163071.360.00002182358
Loss of Function2.612543.60.5740.00000229448

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007560.000730
Ashkenazi Jewish0.000.00
East Asian0.0001670.000163
Finnish0.00009610.0000924
European (Non-Finnish)0.0003430.000325
Middle Eastern0.0001670.000163
South Asian0.0003280.000327
Other0.0003300.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Non-receptor tyrosine-protein and serine/threonine- protein kinase that is implicated in cell spreading and migration, cell survival, cell growth and proliferation. Transduces extracellular signals to cytosolic and nuclear effectors. Phosphorylates AKT1, AR, MCF2, WASL and WWOX. Implicated in trafficking and clathrin-mediated endocytosis through binding to epidermal growth factor receptor (EGFR) and clathrin. Binds to both poly- and mono-ubiquitin and regulates ligand-induced degradation of EGFR, thereby contributing to the accumulation of EGFR at the limiting membrane of early endosomes. Downstream effector of CDC42 which mediates CDC42-dependent cell migration via phosphorylation of BCAR1. May be involved both in adult synaptic function and plasticity and in brain development. Activates AKT1 by phosphorylating it on 'Tyr-176'. Phosphorylates AR on 'Tyr-267' and 'Tyr-363' thereby promoting its recruitment to androgen-responsive enhancers (AREs). Phosphorylates WWOX on 'Tyr- 287'. Phosphorylates MCF2, thereby enhancing its activity as a guanine nucleotide exchange factor (GEF) toward Rho family proteins. Contributes to the control of AXL receptor levels. Confers metastatic properties on cancer cells and promotes tumor growth by negatively regulating tumor suppressor such as WWOX and positively regulating pro-survival factors such as AKT1 and AR. Phosphorylates WASP (PubMed:20110370). {ECO:0000269|PubMed:10652228, ECO:0000269|PubMed:11278436, ECO:0000269|PubMed:16247015, ECO:0000269|PubMed:16257963, ECO:0000269|PubMed:16472662, ECO:0000269|PubMed:17038317, ECO:0000269|PubMed:18262180, ECO:0000269|PubMed:18435854, ECO:0000269|PubMed:19815557, ECO:0000269|PubMed:20110370, ECO:0000269|PubMed:20333297, ECO:0000269|PubMed:20383201}.;
Pathway
Focal Adhesion;Oxidative Damage;EGF-EGFR Signaling Pathway;G13 Signaling Pathway;EGFR1;CDC42 signaling events (Consensus)

Recessive Scores

pRec
0.423

Intolerance Scores

loftool
0.779
rvis_EVS
-0.72
rvis_percentile_EVS
14.28

Haploinsufficiency Scores

pHI
0.412
hipred
Y
hipred_score
0.610
ghis
0.616

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.990

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tnk2
Phenotype

Gene ontology

Biological process
endocytosis;cell surface receptor signaling pathway;small GTPase mediated signal transduction;phosphorylation;cell differentiation;negative regulation of GTPase activity;peptidyl-tyrosine autophosphorylation;regulation of cell population proliferation;positive regulation of peptidyl-tyrosine phosphorylation;regulation of clathrin-dependent endocytosis
Cellular component
nucleus;cytoplasm;endosome;plasma membrane;clathrin-coated pit;adherens junction;membrane;clathrin-coated vesicle;cytoplasmic vesicle membrane;perinuclear region of cytoplasm;Grb2-EGFR complex;cytoophidium
Molecular function
protein serine/threonine kinase activity;protein serine/threonine/tyrosine kinase activity;protein tyrosine kinase activity;non-membrane spanning protein tyrosine kinase activity;GTPase inhibitor activity;epidermal growth factor receptor binding;protein binding;ATP binding;ubiquitin protein ligase binding;identical protein binding;metal ion binding;WW domain binding